BGM Group Ltd.
BGM Nasdaq· Pharmaceutical Preparations
KIRA · Stoqly’s AI analyst, in plain words
- BGM Group Ltd. had $37.9M of revenue in fiscal 2025, up 51.1% on the year before. Over five years, revenue changed −5.4% a year on average.
- Its operating margin was −33.2%, down 30.9 pts: of every 100 in sales, about −33 is left after running the business.
- BGM Group Ltd. lost $19.9M in fiscal 2025.
- Free cash flow was −$3.9M in fiscal 2025, −10.4% of revenue.
Market cap
—
P/E
—
Revenue
$37.9M
Net income
−$19.9M
Free cash flow
−$3.9M
Operating margin
−33.2%
BGM Group Ltd. in 30 seconds · fiscal 2025
Are sales growing?
+51.1%
Yes. Sales grew 51.1% last year.
Does it make a profit?
−52.6%
No. It lost money last year.
Does profit turn into cash?
−10.4%
No. It spent more cash than it brought in.
How healthy are the accounts?
2 / 8
Weak. It passes 2 of 8 health tests.
What BGM Group Ltd. does
No business description yet.
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 20-F · Jul 21, 2026
- Legal name
- BGM Group Ltd.
- CIK
- 0001779578
BGM Group Ltd. · BGM
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $57.1M | $64.9M | $46.5M | $25.1M | $37.9M |
| Revenue growth | 14.1% | 13.6% | −28.3% | −46.0% | 51.1% |
| Net interest income | −$0.1M | $0.0M | $0.1M | — | — |
| Gross margin | 9.9% | 9.6% | 3.8% | 16.4% | 16.6% |
| Operating margin | 4.2% | 3.2% | −5.6% | −2.2% | −33.2% |
| Net income | $3.2M | $1.1M | −$7.8M | −$1.4M | −$19.9M |
| Net margin | 5.5% | 1.7% | −16.7% | −5.7% | −52.6% |
| Diluted EPS | $0.09 | $0.15 | −$1.08 | −$0.20 | −$0.18 |
| Cash | |||||
| Cash from operations | $0.3M | $12.7M | $0.3M | $0.5M | −$2.4M |
| Capital expenditure | $1.5M | $2.0M | $0.2M | $0.2M | $1.6M |
| Free cash flow | −$1.1M | $10.6M | $0.1M | $0.3M | −$3.9M |
| FCF margin | −2.0% | 16.4% | 0.3% | 1.2% | −10.4% |
| Dividends paid | — | — | $1.8M | — | — |
| Share count change | 13.6% | −78.8% | 0.0% | 0.0% | 1,467.3% |
| Debt and strength | |||||
| Cash and short-term investments | $10.5M | $14.3M | $8.5M | $9.8M | $9.8M |
| Shareholders' equity | $54.9M | $53.1M | $42.8M | $42.7M | $391M |
| Current ratio | 2.2x | 3.3x | 5.2x | 3.4x | 1.2x |
| Interest coverage | 41.4x | — | — | — | — |
| Returns and quality | |||||
| Return on equity | 7.8% | 2.0% | −16.2% | −3.4% | −9.2% |
| Return on tangible equity | 6.0% | 2.1% | −19.8% | −3.8% | −56.1% |
| Piotroski F-score | 3 | 6 | 4 | 5 | 2 |
| Altman Z'' | 5.9 | 8.9 | 10.1 | 7.8 | 9.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
BGM Group Ltd. · BGM
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Source: SEC EDGAR XBRL filings (CIK 0001779578). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.